Patents by Inventor Hermann Ammon

Hermann Ammon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity
    Publication number: 20070129317
    Abstract: The invention concerns the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preventing and/or combatting diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of: normal leucocytic elastase or plasmin activity, in human or veterinary medicine. The invention further concerns the use of pure boswellic acid or a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preparing a medicament for treating diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of normal leucocytic elastase or plasmin activity, in human or veterinary medicine.
    Type: Application
    Filed: January 3, 2007
    Publication date: June 7, 2007
    Applicant: Hermann P.T. Ammon
    Inventors: Hermann Ammon, Hasan Safayhi
  • Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity
    Publication number: 20050209169
    Abstract: The invention concerns the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preventing and/or combatting diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of: normal leucocytic elastase or plasmin activity, in human or veterinary medicine. The invention further concerns the use of pure boswellic acid or a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preparing a medicament for treating diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of normal leucocytic elastase or plasmin activity, in human or veterinary medicine.
    Type: Application
    Filed: December 3, 2004
    Publication date: September 22, 2005
    Applicant: Hermann P.T. Ammon
    Inventors: Hermann Ammon, Hasan Safayhi